R. Rodriguez-Roisin (Barcelona, Spain), J. Wedzicha (London, United Kingdom)
Implementation of NIV in a respiratory ward for patients with COPD exacerbation: from theory to practice
I. L. Titlestad, H. D. Madsen (Odense, Denmark)
|  |
Does oxidative stress diminish after recovery from COPD exacerbation?
J. Musil, J. Chládek (Prague, Hradec Králové, Czech Republic)
| |
Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
Deterioration in health with infective COPD exacerbation is largely independent of baseline airway obstruction
P. W. Jones, R. R. Wilson, S. Spencer, P. P. Sagnier (London, Uxbridge, United Kingdom)
| |
Evaluation of markers for exacerbations of COPD
L. G. Franciosi, C. P. Page, B. R. Celli, M. Cazzola, M. J. Walker, M. Danhof, K. F. Rabe, O. E. Della Pasqua (Leiden, Netherlands; London, Greenford, United Kingdom; Boston, United States Of America; Naples, Italy; Vancouver, Canada)
| |
Physicochemical and pathophysiologic effects of oscillating endobronchial positive expiratory pressure in acute exacerbation of COPD
N. Y. Azab, A. F. Katat, M. M. Abdelaziz (Shebin Elkom, Alexandria, Egypt)
| |
To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period
G. Mates, M. W. Daley, T. Magnall, B. C. Leahy (Manchester, United Kingdom)
| |
The role of bronchial bacterial infection/colonization in acute exacerbation of COPD
L. Konopkina, T. Pertseva, O. Bratus, O. Shnaider (Dnipropetrovs‘k, Ukraine)
| |
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation
A. Ilvan, E. Kunter, E. Demirer, K. Avsar, Z. Kartaloglu, M. Oztosun (Istanbul, Turkey)
| |
Hypomagnesaemia prevalence in chronic obstructive pulmonary from years 2000 to 2001 in Hospital de Clinicas de Londrina
A. Cerci Neto, O. F. Ferreira Filho (Londrina, Brazil)
| |
Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation
E. Sen, S. Ozcan, P. Onen, B. Gulbay, O. Yildiz, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey)
| |
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period
O. Akbay, G. Onde Ucoluk, B. Samurkasoglu, A. Gozu, F. Ugurman, B. Akkalyoncu (Ankara, Turkey)
| |
Predictors of exacerbations of COPD
R. Siva, M. Berry, C. E. Brightling, R. Green, I. D. Pavord (Leicester, United Kingdom)
| |
Formoterol (Modulite), tiotropium and their combination in patients with acute exacerbation of chronic bronchitis: preliminary data
F. Di Marco, M. Verga, P. Santus, M. Cazzola, M. Mondoni, E. Belloli, S. Centanni (Milan, Naples, Italy)
| |
Reduction in acute hospital resource use by patients with severe COPD: an integrated facilitated care model
H. Teichtahl, D. Pilbrow, H. Sinnott, S. Bird (Footscray, Australia)
| |
Chronic obstructive pulmonary disease and nosocomial infections
P. S. Borade, D. K. C. Lee (Ipswich, United Kingdom)
| |
Comorbidity in the patients with severe COPD treated in intensive respiratory care unit
L. Ristic, M. Rancic, I. Stankovic, T. Pejcic, M. Radovic (Nis, Serbia And Montenegro)
| |
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
D. G. Kim, K. S. Eom, T. R. Shin, M. J. Jeon, Y. B. Park, C. H. Kim, S. H. Jang, M. G. Lee, I. G. Hyun, K. S. Jung (Pyungchon-dong, Dongan-gu, Anyang-si, Republic Of Korea)
| |
Characteristics of patients admitted to a respiratory hospital due to COPD exacerbation
E. Giugno, O. Caberlotto, P. Malamud, L. Grodnistzky, M. F Acquier, V. Morandi (Florida, Argentina)
| |
Treatment changes, readmission rates and mortality in a COPD hospital at home scheme
S. Hoyle, S. Butler, S. Stanton, A. Simpson, J. Simpson (Manchester, United Kingdom)
| |